ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 55 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2015. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $26,000 | -13.3% | 14,140 | +31.2% | 0.04% | +3800.0% |
| Q4 2019 | $30,000 | -9.1% | 10,780 | -50.3% | 0.00% | -50.0% |
| Q3 2019 | $33,000 | -55.4% | 21,674 | -38.9% | 0.00% | -50.0% |
| Q2 2019 | $74,000 | -46.0% | 35,449 | -0.6% | 0.00% | -55.6% |
| Q4 2018 | $137,000 | -60.7% | 35,658 | -3.6% | 0.01% | -43.8% |
| Q3 2018 | $349,000 | +384.7% | 36,991 | +155.3% | 0.02% | +433.3% |
| Q1 2018 | $72,000 | -73.3% | 14,491 | -72.9% | 0.00% | -75.0% |
| Q4 2017 | $270,000 | +159.6% | 53,482 | +216.8% | 0.01% | +140.0% |
| Q3 2017 | $104,000 | -24.1% | 16,882 | -25.4% | 0.01% | 0.0% |
| Q3 2015 | $137,000 | – | 22,617 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |